Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice

[1]  D. Campion,et al.  Hyperprolinemia is a risk factor for schizoaffective disorder , 2005, Molecular Psychiatry.

[2]  S. Almashanu,et al.  Functional consequences of PRODH missense mutations. , 2005, American journal of human genetics.

[3]  R. Murray,et al.  Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  Maria Karayiorgou,et al.  Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia , 2004, Nature Genetics.

[5]  T. Sotnikova,et al.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[7]  Patricia S. Goldman-Rakic,et al.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia , 2004, Psychopharmacology.

[8]  J. Stemmelin,et al.  Gene expression profiling following chronic NMDA receptor blockade‐induced learning deficits in rats , 2003, Synapse.

[9]  J. Lieberman,et al.  A comprehensive analysis of 22q11 gene expression in the developing and adult brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Kandel,et al.  Presynaptic BDNF Required for a Presynaptic but Not Postsynaptic Component of LTP at Hippocampal CA1-CA3 Synapses , 2003, Neuron.

[11]  T. Mackay,et al.  The genetic architecture of odor-guided behavior in Drosophila: epistasis and the transcriptome , 2003, Nature Genetics.

[12]  K. Rayevsky,et al.  Chronic neonatal N-methyl-d-aspartate receptor blockade induces learning deficits and transient hypoactivity in young rats , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  Susumu Tonegawa,et al.  Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[15]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[16]  B. Lipska,et al.  Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function , 2003, Neuroscience.

[17]  D. Javitt,et al.  Subchronic Continuous Phencyclidine Administration Potentiates Amphetamine-Induced Frontal Cortex Dopamine Release , 2003, Neuropsychopharmacology.

[18]  G. Abecasis,et al.  Genetic variation in the 22q11 locus and susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[20]  D. Campion,et al.  PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. , 2002, Human molecular genetics.

[21]  B. Moghaddam,et al.  Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat , 2002, Behavioural Brain Research.

[22]  Ellen M Wijsman,et al.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Robert Lalonde,et al.  The neurobiological basis of spontaneous alternation , 2002, Neuroscience & Biobehavioral Reviews.

[24]  William Stafford Noble,et al.  Exploring Gene Expression Data with Class Scores , 2001, Pacific Symposium on Biocomputing.

[25]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Marc Laruelle,et al.  The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies , 2000, Brain Research Reviews.

[27]  J. Lieberman,et al.  Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization , 1999, Molecular Psychiatry.

[28]  P. Greengard,et al.  Beyond the Dopamine Receptor: Review the DARPP-32/Protein Phosphatase-1 Cascade , 1999 .

[29]  M. Karayiorgou,et al.  The gene encoding proline dehydrogenase modulates sensorimotor gating in mice , 1999, Nature Genetics.

[30]  J. Lieberman,et al.  Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases , 1999, Biological Psychiatry.

[31]  V. Pickel,et al.  The Mammalian Brain High-Affinity l-Proline Transporter Is Enriched Preferentially in Synaptic Vesicles in a Subpopulation of Excitatory Nerve Terminals in Rat Forebrain , 1999, The Journal of Neuroscience.

[32]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[33]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[34]  R. Roth,et al.  Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the Rat , 1997, Neuropsychopharmacology.

[35]  J. Nadler,et al.  Proline-induced potentiation of glutamate transmission , 1997, Brain Research.

[36]  J. Nadler,et al.  Sodium-dependent proline and glutamate uptake by hippocampal synaptosomes during postnatal development. , 1997, Brain research. Developmental brain research.

[37]  J. Meador-Woodruff,et al.  Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems , 1996, Brain Research.

[38]  R. Shprintzen,et al.  Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[40]  S. Kaakkola,et al.  General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. , 1994, General pharmacology.

[41]  A. Macdermott,et al.  L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons. , 1992, Molecular pharmacology.

[42]  Joseph E LeDoux,et al.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.

[43]  J. Glowinski,et al.  Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D‐1 Dopamine Receptor , 1991, The European journal of neuroscience.

[44]  P. Seeman,et al.  Dopamine receptors and the dopamine hypothesis of schizophrenia , 1987, Synapse.